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Abstract
Background: The diagnosis of allergic contact dermatitis should be confirmed by skin
patch tests. Distinguishing between irritant and allergic reactions is sometimes
difficult.
Objectives: To analyse the in vivo morphological changes in patch test reactions
compared to healthy skin, and to detect subclinical changes in doubtful reactions
using optical coherence tomography (OCT). To develop an OCT-based algorithm to
support patch-test grading.
Methods: One hundred twenty-nine skin patch-test areas were scanned with OCT to
evaluate the following features: architectural and vascular morphology, epidermal
thickness, optical attenuation coefficient (AC), and blood flow at 0.1, 0.2, and
0.35 mm depth.
Results:Most common OCT features of acute contact allergic reactions in patch tests
were spongiosis with microvesicles (94.8%), macrovesicles (60.3%), and coalescing
vesicles (46.6%), the latter useful in differentiating acute allergic from irritant derma-
titis (P-value < .05). Objective quantitative parameters correlated well with the sever-
ity grade: epidermal thickness due to spongiosis, AC (P-value < .05) and blood flow at
0.2 and 0.35 mm (P-value < .01).
Conclusions: OCT as a noninvasive diagnostic tool, established for skin cancer diag-
nosis, is useful for evaluating contact allergic patch-test reactions. Not only morpho-
logical but also objective features such as blood flow and AC correlate with the
reaction severity. Further studies are needed to explore the differences in irritant and
allergic contact dermatitis.
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1 | INTRODUCTION
Contact dermatitis to environmental allergens is a very common
disease, with an estimated prevalence of 20% in the general popu-
lation.1 It describes a pattern of reaction of the skin to exogenous
agents, caused either by a cell-mediated type IV immune response
(allergic) or not (irritant or toxic). Histologically, a cutaneous
inflammation occurs with spongiosis, vesicle-formation, and vaso-
dilation in the acute phase, which can evolve to a chronic
spongiotic dermatitis with hyperkeratosis, parakeratosis, irregular
acanthosis, and elongation of the rete ridges. Even histology does
not always allow a clear distinction between contact allergic and
irritant or toxic dermatitis.2
The diagnosis is based on an accurate medical history and clinical
examination followed by skin patch tests.3 The latter represents the
diagnostic gold standard and reproduces a contact allergy in an indi-
vidual sensitized to a particular hapten. Standardized concentrations
of allergens in an appropriate vehicle are applied in confined chambers
to the skin of the back (rarely of the extremities) under occlusion.
Reported specificity and sensitivity range between 70% and 80%
depending on the tested substance.4 According to the scoring system,
developed by the International Contact Dermatitis Research Group
(ICDRG), the reaction in patch testing is classified into six groups
based on the specified morphological criteria, ranging from no reac-
tion (0) to extreme positive bullous reaction (+++), with additionally
doubtful (?+) and irritant reactions (IR).5,6 A drawback of patch testing
is that the interpretation of the results is usually influenced by the
observer; hence it is not fully objective.5,7,8 Another issue is the diffi-
culty in distinguishing especially + allergic reactions from weak irritant
contact dermatitis, since erythema and infiltration are present in both
cases.
Various diagnostic modalities have been investigated in attempts
to overcome the subjectivity of patch test grading, and among them
are laser Doppler velocimetry, transepidermal water loss, colorimetry,
infrared thermography, 20-MHz ultrasound A-Scans, high-definition
optical coherence tomography, optoacoustic mesoscopy, dermoscopy,
reflectance confocal microscopy (RCM) and conventional optical
coherence tomography (OCT).9-16 OCT is a noninvasive imaging tech-
nique that can differentiate skin structures, including the stratum cor-
neum, the epidermis, the upper dermis, skin appendages, and blood
vessels. It is particularly suitable for the diagnosis of epithelial skin
tumors and monitoring of resolution/persistence/relapse/progression
following nonsurgical therapies, but it is also used in inflammatory and
infectious diseases.17 In this prospective study, we examined the
in vivo morphological changes of skin patch tests in a cohort of
129 skin areas using standard and dynamic OCT. The aim of this study
was to analyze the morphological skin changes in vivo in acute allergic
and irritant contact dermatitis compared to healthy skin, and eventu-
ally to detect subclinical changes in unclear reactions. Furthermore,
we aimed at developing an OCT-based algorithm for additional objec-
tive parameters in patch-test grading to support clinical evaluation
especially in doubtful reactions.
2 | MATERIALS AND METHODS
OCT images sized 6 mm × 6 mm down to a skin depth of about 1 to
1,5 mm were acquired using the commercially distributed Vivosight
(Michelson Diagnostics, Maidstone, Kent, UK). This frequency domain
OCT is based on Michelson interferometry, has a lateral optical reso-
lution of 7.5 μm, and an axial resolution of 10 μm, combined with a
penetration depth of up to 1 to 1.5 mm. Its laser source (HSL 2000;
Santec Corporation, Komaki, Japan) has a wavelength of 1305 nm.
The device has a handheld probe, which is provided with a series of
plastic spacers to adjust the focus to different skin sites. The dynamic
mode allows the visualization of blood flow and vessels simulta-
neously with morphologic features of the tissue. A more detailed
description of the device is provided elsewhere.18
Patients with suspected allergic contact dermatitis undergoing
patch testing in our allergy outpatient department were enrolled in
the study. Patch testing was performed according to the international
and German guidelines on the upper back and removed after
48 hours. Conclusive grading was performed following the German
guidelines after 3 days, and also after 7 or 10 days for
aminoglycosides, p-phenylenediamine, and metals.6
A total of 129 skin areas from 29 patients with positive patch-test
reactions (10 male and 19 female, mean age 48.5, range 22 to
80 years) (Supplementary Table S1) in our allergy department were
scanned in both en face and dynamic mode with OCT. Seventy-three
positive (44 +, 27 ++, 2 +++), 16 unclear, 16 irritant reactions to
sodium lauryl sulfate (SLS), and 23 healthy skin controls were
acquired. Every area was evaluated in its center by three dermatolo-
gists blinded to the clinical diagnosis. Good interobserver agreement
was found for all parameters (Cohen's kappa coefficient: 0.7); dis-
agreements were solved by the involvement of a fourth senior derma-
tologist. The following morphologic OCT features were analyzed:
OCT spongiosis was characterized by enlarged interkeratinocyte
spaces, blurred dermo-epidermal junction (DEJ), pustules, erosions,
bright spots, and epidermal vesicles (subcorneal or deep intra-
epidermal). Vesicles were subdivided arbitrarily into microvesicles
(smaller than 0.1 mm), not always clearly distinguishable from
enlarged interkeratinocyte spaces in a spongiotic epidermis due to
OCT spatial resolution, and macrovesicles (larger than 0.1 mm). Fur-
ther analyzed features included superficial and deep vasodilation and
vascular morphology in en face and dynamic. Epidermal thickness was
computed based on an average of 10 repeated measurements, and
the OCT software calculated this average.
The optical attenuation coefficient (AC) and blood flow analysis
were calculated using the software tool “OCT Analyse-OCT research
tool” provided by Michelson Diagnostics. Optical AC corresponds to
the average OCT signal related to depth across the whole scan and
can be interpreted as a marker for signal disruption. Capillary blood
flow is quantified by calculating the signal intensity of speckle vari-
ance produced by local movement (=dynamic) at different depths.
Objective measurements of blood flow from 0.1 to 0.35 mm from the
skin surface in 0.5 mm intervals were obtained.
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For statistical analysis, continuous variables were described by mean,
standard deviation, and 95% confidence interval by total sample and
by reaction grades. Blood flow at 0.1 mm, 0.20 mm, and 0.35 mm;
ACs, and epidermal thickness were compared across the different
reaction grades and the healthy skin using one-way analyses of vari-
ance (ANOVAs). To compare the categorical variables, we used the
chi-square test of independence. Statistical significance was deter-
mined at the level of P-value < .05. All statistical analyses were com-
pleted using IBM SPSS Statistics.
The study was conducted according to the principles of the Dec-
laration of Helsinki and international guidelines concerning human
studies. It was approved by the local ethics committee (Nr.17-699),
and written informed consent was obtained from each subject.
3 | RESULTS
The following OCT patterns were evaluated: macro- and micro-
morphologic features, grading, vascular pattern, blood flow measure-
ments, and AC (Table 1).
3.1 | Morphologic patterns
A blurred (interrupted) DEJ was visible in 33.3% of +, 83.3% of ++,
100% of +++ positive patch-test reactions and in 42.9% of irritant
reactions in comparison to healthy skin (4.3%), thus positively corre-
lating to the clinical grade (P < .01).
Microvesicles were present in 87.9% of positive patch-test reac-
tions (84.4% of 1+, 91.7% of 2+, 100% of 3+), 80.0% of IR, and 13.0%
of healthy skin. OCT spongiosis was found in 91.4% of positive patch
test reactions (87.5% of 1+, 95.8% of 2+, 100.0% of 3+), 93.3% of IR,
and 17.4% healthy skin. Clustered together, they were present in
94.8% of positive patch-test reactions (93.8% of 1+, 95.8% of 2+,
100.0% of 3+), 93.3% of IR, and 26.1% of healthy skin. There was a
statistically significant difference compared to healthy skin (P < .01)
but not between contact allergic patch-test reactions (reproducing
allergic contact dermatitis [acute allergic contact dermatitis (ACD)])
and IR (P < .082).
Macrovesicles (60.3% of positive reactions vs 26.7% of IR) and
deep vesiculation at the level of lower stratum granulosum and stra-
tum spinosum (46.6% of positive reactions vs 13.3% of IR) were sta-
tistically significantly more frequently detected in positive patch test
reactions compared to irritant contact dermatitis induced by SLS (P <
.05) (Figures 5 and 6). Deep blistering (near the DEJ) was present in
46.6% of positive patch-test reactions compared to 13.3% of IR and
0.0% of healthy skin, significantly differing in all groups (P < .01).
Erosions were found in 19.0% of positive patch-test reactions
(15.6% of +, 25.0% of ++, 0.0% of +++), 26.7% of IR, and 0.0% of
healthy skin. Pustules appeared in 53.4% of positive patch-test reac-
tions (40.6% of +, 70.8% of ++, 50.0% of +++), 26.7% of IR, and 4.3%
of healthy skin. Bright spots were found in 86.2% of positive patch-
test reactions (81.3% of +, 91.7% of ++, 100.0% of +++), 93.3% of IR,
and 8.7% of healthy skin. The above-mentioned parameters did not
differ significantly between contact allergic positive patch-test reac-
tions and IR (Figure 1).
3.2 | Vascular pattern
The following vascular patterns were analyzed: arborizing vessels, ser-
piginous vessels, linear vessels, dotted vessels, superficial vasodilation,
and deep vasodilation. Large serpiginous vessels (64.3% of positive
patch tests vs 15.8% of healthy skin), as well as superficial (89.7% of
positive patch tests vs 34.8% of healthy skin) and deep vasodilation
(47.4% of positive patch tests vs 8.7% of healthy skin), were signifi-
cantly more represented in positive patch test reactions compared to
healthy skin (P < .01). Of interest, large serpiginous vessels were sig-
nificantly more frequent in irritant reactions compared to healthy skin
(50.0% vs 15.8% respectively, P < .035).
3.3 | Epidermal thickness
Mean epidermal thickness was 0.152 mm (± 0.053),
(0.173 mm ± 0.057 in positive patch tests vs 0.144 mm ± 0.025 IR vs
0.108 mm ± 0.017 in healthy skin) (Figure 2A). Significantly higher
epidermal thickness, increasing with the clinical grade (Figure 2B), was
TABLE 1 Mean epidermal thickness (EC) in mm, cutaneous blood flow rate in mm/s, and attenuation coefficient in examined positive patch-














ACD Global 0.1733 ± 0.0575 0.0230 ± 0.0430 0.0587 ± 0.0494 0.1628 ± 0.0686 1.7200 ± 0.3299
ACD + 0.1521 ± 0.0512 0.0133 ± 0.0132 0.0403 ± 0.3355 0.1456 ± 0.0764 1.7737 ± 0.2548
ACD ++ 0.1967 ± 0.0515 0.0341 ± 0.0626 0.0807 ± 0.0583 0.1802 ± 0.0566 1.6539 ± 0.4017
ACD +++ 0.2350 ± 0.0919 0.0325 ± 0.0348 0.0590 ± 0.0514 0.1798 ± 0.0280 1.45
IR 0.1440 ± 0.0256 0.0081 ± 0.0039 0.0265 ± 0.0155 0.1082 ± 0.0415 1.7177 ± 0.2053
Unclear 0.1420 ± 0.0443 0.0125 ± 0.0106 0.0409 ± 0.0304 0.1346 ± 0.0544 1.8775 ± 0.2121
Healthy skin 0.1516 ± 0.0526 0.0084 ± 0.0114 0.0195 ± 0.0121 0.0998 ± 0.0338 1.9086 ± 0.2248
Abbreviation: ACD, acute allergic contact dermatitis.
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observed in positive patch-test reactions (0.152 mm ± 0.052 in 1+,
0.197 mm ± 0.051 in 2+, 0.235 mm ± 0.092 in 3+) (P < .01). The dif-
ference was statistically significant, also compared to healthy skin (P
< .05).
3.4 | Cutaneous blood flow rate at a depth
of 0.1 mm
Mean cutaneous blood flow rate at a depth of 0.1 mm was
0.0167 ± 0.0329 mm/s (0.0230 ± 0.0430 in contact allergic patch test
reactions and 0.0081 ± 0.0037 in IR and 0.0084 ± 0.0114 in healthy
skin) (Figure 3A) There was no significant difference across the differ-
ent clinical groups (P = .083) (Figure 3B).
3.5 | Cutaneous blood flow rate at a depth
of 0.2 mm
Mean cutaneous blood flow rate at a depth of 0.2 mm was
0.0441 ± 0.0419 mm/s (0.0587 ± 0.0430 in contact allergic patch test
reactions, 0.0265 ± 0.0155 in IR and 0.0195 ± 0.0121 in healthy skin)
(Figure 3A). A statistically significant difference between all clinical
grades (P < .01) and compared to healthy skin was recorded
(Figure 3B).
3.6 | Cutaneous blood flow rate at a depth of
0.35 mm
Mean cutaneous blood flow rate at 0.35 mm was
0.1388 ± 0.0638 mm/s (0.1628 ± 0.0686 in contact allergic patch test
reactions, 0.1059 ± 0.0406 in IR and 0.0998 ± 0.0338 in healthy skin)
(Figure 3A) It significantly increased proportional to the clinical grade
from 1+ to 2+ (P < .01) (Figure 3B).
3.7 | Attenuation coefficient
Mean AC was 1.781 ± 0.292. There was a statistically significant dif-
ference in AC among all groups (P < .05), with a mean value of 1.73 in
positive patch tests, 1.72 in IR reactions, and 1.91 in healthy skin
(Figure 4A). AC was statistically significantly lower (P < .01) in positive
patch-test reactions compared to healthy skin, and was inversely
related to the grading (1.77 in + reactions, 1.66 in ++ reactions, 1.45
in +++ reactions) (P < .05) (Figure 4B).
3.8 | OCT grading
An OCT grading of patch-test reactions was performed, based on the
criteria for clinical evaluation of patch testing. OCT spongiosis and
microvesicles were graded with +, macrovesicles with ++, and coales-
cent vesicles with +++ (Figure 5). The re-evaluation resulted in a
higher grading in 54.6% of + cases and 66.7% of ++ cases. Lower
grading occurred in 6.1% of +, in 8.4% of ++, and 50% of +++ positive
F IGURE 1 Frequency of
morphological optical coherence
tomography features of examined
positive patch-test reactions, irritant
reactions, and healthy skin controls
F IGURE 2 Mean epidermal thickness in mm measured by optical
coherence tomography in (A) examined positive patch-test reactions
(ACD), irritant reactions (IRs), and healthy skin controls. (B) Examined
positive patch-test reactions subdivided by clinical grading (+, ++, +++)
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patch tests. All clinically unclear lesions could be OCT graded, with no
reaction (grade 0) in 13.3%, + in 20%, ++ in 20%, and +++ in 46.7%.
4 | DISCUSSION
Patch-test reactions are assessed by visual inspection, supported by
palpation, and based on morphological clinical criteria (erythema, infil-
tration, papules, vesicles, confluent vesicles).5,6,19 However, even
reactions classified as positive could turn out to be irritant, so that a
clinical follow-up after 1 or 2 days may be required. To detect an
increased skin irritability at the time of testing, the German standard
patch-test series includes sodium lauryl sulfate 0.25% aq. as an irritant
control to use as a comparison for unclear reactions.6 Thus it can be
difficult to properly grade patch-test reactions, especially in doubtful
cases, and interobserver variability even among expert readers is
unavoidable.
Since surgical biopsies are painful, expensive and time-consuming,
and histopathology does not always allow a precise distinction
between contact allergic and irritant patch test reactions, various non-
invasive diagnostic techniques were used to further investigate patch
test reactions experimentally.15,16,20-23 Dermoscopy is cheap and
available worldwide; pilot studies correlated erythema, vesicles,
orange-yellowish patchy areas, and vessels with allergic reactions
compared to irritant reactions; nonetheless, additional studies on
doubtful reactions are needed.15,16 Among further noninvasive
diagnostic tools, RCM, OCT, and optoacoustic mesoscopy showed the
most promising results.9-14,24 However, RCM is more time consuming
than OCT and does not provide an immediate, intuitive comparison
with histology in nonexpert physicians. Optoacoustic mesoscopy was
able to associate a higher fragmentation of skin vasculature and a
lower ratio of low-to-high frequency acoustic signals to allergic reac-
tions compared to irritant reactions in a pilot study24; however, use of
the device is still limited to clinical research. The few studies with
OCT reported to date were based on a small number of samples and
did not systematically include irritant controls and unclear reactions.
Gamblicher et al analyzed 20 positive patch-test reactions with the
high-definition OCT by AGFA (not commercially available anymore),
observing pronounced skin folds, thickened and/or disrupted entrance
signals, increase in epidermal thickness, and clearly demarcated signal-
free cavities within the epidermis with considerable reduction of
dermal reflectivity.10 Our group observed OCT morphological correla-
tions to patch-test grading in five nickel-positive patients, detecting
increased entrance signal and epidermal thickness compared to
healthy areas, acute OCT spongiosis and vesiculation, vasodilation,
and an edema in the papillary dermis visible as lower dermal reflectiv-
ity.13 The University of Miami studied seven patients and identified a
significant increase of the AC and of cutaneous blood flow at a
0.35-mm depth from 0 to ++.12
In the current study, we examined +, ++, and +++ patch-test reac-
tions, together with IR and unclear reactions, and compared them to
healthy skin. Allergic and irritant contact dermatitis share common
(a)
(b)
F IGURE 3 Mean cutaneous blood
flow rate at different depths (0.1, 0.2,
0.35 mm) measured by dynamic
optical coherence tomography in
(A) examined positive patch test
reactions (ACD), irritant reactions
(IRs), and healthy skin controls.
(B) Examined positive patch-test
reactions subdivided by clinical
grading (+, ++, +++)
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histopathological features, such as epidermal spongiosis and intra-
epidermal vesicle formation as well as inflammatory cell infiltration in
dermis and epidermis. However, spongiosis, exocytosis, and vesicles
or bullae formation due to confluence of vesicles are more common
and evident in allergic contact dermatitis. Focal epidermal infiltration
and mononuclear perivascular infiltration in the dermis are common
findings in allergic and irritant contact dermatitis. Such infiltrates may
sometimes be associated with dilation of lymphatic or blood vessels.
In irritant dermatitis, necrosis and pustules are more frequently
observed and the perivascular infiltrate can vary from mononucleated
to multinucleated. Edema and spongiosis are less common in irritant
than in allergic dermatitis.25
Intuitively, an increase in epidermal thickness (ET) due to
spongiosis and vesicle formation in acute allergic contact dermatitis is
expected. We registered a statistically significant difference in ET
measured by OCT, also in line with previous observations.10 Average
ET was significantly lower (P < .01) in healthy skin compared to posi-
tive patch-test reactions and positively correlated to patch-test grad-
ing. Surprisingly, ET in IR significantly diverged from both healthy skin
and positive patch test reactions (P < .05), the average ET being half-
way between positive reactions and IR.
Concerning macroscopic OCT patterns, we found spongiosis, blis-
tering, pustules, bright spots, erosions, and poorly defined DEJ to be
statistically significantly prevalent in acute contact dermatitis and IR
compared to healthy skin (P < .01). Acute spongiosis (intercellular
edema, due to abnormal accumulation of fluid) is visible as increased
ET, brighter keratinocytic contours, darker enlarged intercellular
spaces, and microvesicles. These were not always clearly distinguish-
able from enlarged interkeratinocyte spaces, due to OCT spatial reso-
lution. Vesicles appeared in general as roundish low-signal cavities in
the epidermis, variable in size, and sometimes containing bright mate-
rial (corresponding to acantholytic cells and inflammatory infiltrate).
They could coalesce in ++ and +++ patch-test reactions and tended to
be also localized in the deeper epidermis in ++ and +++ patch-test
reactions. Pustules were clearly localized as subcorneal or epidermal
cavities filled with bright material, sometimes totally filled. Erosions
were rarely visible. In our analysis, the presence of macrovesicles and
deep vesiculation in the lower stratum granulosum and stratum spi-
nosum was statistically significantly higher in positive patch-test reac-
tions compared to irritant contact dermatitis induced by SLS (P < .05)
(Figures 5 and 6).
Because OCT does not provide a cellular resolution, it is not pos-
sible to identify single inflammatory cells. However, it is hypothesized
that conglomerates of them are visible as bright spots in the epider-
mis; this remains uncertain as also sweat ducts and parakeratotic
nucleated cells have been described as bright spots previously.26
Probably due to the spongiosis and the resulting altered signal
transmission to the dermis, both deep vasodilation and the DEJ were
difficult to visualize in positive patch tests and in irritant reactions
compared to healthy skin. A blurred DEJ positively correlated with the
clinical grade; as a matter of fact it was barely visible not only in pres-
ence of macrovesicles but also in lower grade reactions with
spongiosis and microvesicles.
A morphological analysis of blood vessels found that dotted ves-
sels were present in all types of lesions. Linear and large serpiginous
vessels en face were significantly more frequently represented in pos-
itive reactions compared to healthy skin (P < .05). In vertical mode, we
observed a significant prevalence of superficial vasodilation in positive
reactions compared to healthy skin (P < .05). We reported a preva-
lence of small and large serpiginous vessels in IR, although not signifi-
cantly differing from positive reactions; large serpiginous vessels were
significantly more frequent in IR compared to healthy skin (P < .05).
Every operator dependent technique, also OCT a (especially con-
cerning the evaluation of morphological features) is subject to inter-
observer variability; hence, some objective parameters can
complement the investigation. For example, speckle variance analysis
is of outmost importance for a correct interpretation of blood flow,
since massive interpersonal variability associated with disturbing fac-
tors (such as the immediate effect of pressure through the OCT probe,
the occlusive effect of patch tests, sweating, palpation) negatively
influences the visual assessment.
In the speckle variance analysis, OCT blood flow at 0.2 mm and at
0.35 mm depth (upper dermis) was significantly higher in ECT positive
patch tests compared to IR reactions (P < .01) and healthy skin (P <
.01). However, IR reactions could not be further distinguished from
healthy skin or unclear reactions. We did not find any statistically sig-
nificant differences in the blood flow analysis at a depth of 0.1 mm,
probably due to the influence of the above-discussed external factors
such as the pressure of the OCT detector during the examination.
F IGURE 4 Mean attenuation coefficient (AC) measured by optical
coherence tomography in (A) examined positive patch-test reactions
(ACD), irritant reactions (IRs), and healthy skin controls. (B) Examined
positive patch-test reactions subdivided by clinical grading (+, ++, +++)
6 RUINI ET AL.
Optical AC is also emerging as an important tissue parameter
for measuring how quickly incident light is attenuated when
passing through a medium, and this is a function of the underlying
medium properties. Loss of light in tissue can be caused by absorp-
tion, scattering, or a combination of both.27 It was hypothesized
that homogeneous and healthy tissue has a higher AC compared
to pathologic tissue. In fact, AC was statistically significantly lower
(P < .01) in positive patch-test reactions compared to healthy skin
and also inversely correlated with the grading of patch-test reac-
tions. It did not significantly differ between IR and contact allergic
patch-test reactions.
Based on our morphological observation, we performed a retro-
spective OCT grading of patch-test reactions included in the study,
following the known criteria for clinical evaluation (Figure 5). OCT hel-
ped us detect clear-cut features of allergic contact dermatitis, such as
spongiosis and microvesicles, macrovesicles, and coalescent vesicles.
This more objective re-evaluation resulted in a higher patch-test score
in over 50% of + and ++ patch-test reactions and enabled us to assign
a grade to all clinically unclear lesions.
Our study confirmed the hypothesis that OCT is not only useful
in the diagnosis and management of skin cancer but also in a broader
spectrum of skin diseases. The device is helpful in differentiating aller-
gic contact dermatitis and contact allergic patch-test reactions from
unaffected healthy skin, since main histomorphological correlates are
visible. The most important features here are spongiosis with micro-
vesicles, macrovesicles, and coalescing vesicles. In particular,
F IGURE 5 Optical coherence tomography (OCT) images in en face (left) and in en coupe dynamic modus at 0.2 mm (middle) and at 0.35 mm
(right) depth of: one healthy control site (A-C) and three patients with allergic contact dermatitis with a positive patch-test grade + (D-F), ++ (G-I),
and +++ (J-L). Note the difference between the healthy skin layers of the first patient (A) with regular epidermis and normal vascularisation pattern
(B,C), and the mild positive reaction where acute spongiosis (arrow), vesicle formation (star), and vasodilation (diamond) can be identified in OCT
(D-F). Those features, discrete as microvesicles and spongiosis in grade + patch-test reactions (D), are more evident in strongly positive clinical
reactions (G,I) and clearly visible as coalescent vesicles (J) and pronounced vasodilation (K,L) in the last patient
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macrovesicles and deep blistering could help distinguish acute allergic
from irritant dermatitis. OCT can also be used for more objective
patch test grading, also thanks to additional operator-independent
quantitative measurements, such as the analysis of blood flow at 0.2
and 0.35 mm and the AC. In addition, increased ET due to spongiosis
is easy to measure and correlates well with the severity grade. Further
studies are needed to explore the differences in irritant and allergic
contact dermatitis and to further develop standardized diagnostic
algorithms for OCT-aided patch test grading, especially in weak and
doubtful positive reactions.
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